Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PA Pharma Development AB
AB
Active
Org 5591349138
Norrbyvretsvägen 4
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2017
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 434K
-61% vs 2023
EBITDA margin
22.3%
-70% vs 2023
Equity ratio
82.3%
Financial strength
Net profit 2024
SEK 63K
-69% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 434K
-61%
EBITDA
SEK 97K
-70%
Net profit
SEK 63K
-69%
Total assets
SEK 2,3M
-11%
Equity
SEK 1,9M
-10%
Employees
—
—
Company information
Legal name
PA Pharma Development AB
Org number
5591349138
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 november 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bidra och medvrka vid utveckling av nya produkiter inom life science samt därmed förenlig verksamhet.
Contact
Address
Norrbyvretsvägen 4
Email
paul@papharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Botkyrka
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2020
2M
2021
2M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 543
1 839
1 863
1 127
434
Staff expenses
—
—
−742
−722
−241
EBITDA
773
1 008
933
328
97
Depreciation & amort.
−0
−0
—
—
—
EBIT
773
1 008
933
328
97
Net financials
−1
−3
−0
11
12
Profit before tax
772
1 005
696
254
81
Tax
−253
−208
−147
−53
−18
Net profit
519
797
549
201
63
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 905
2 210
2 674
2 610
2 333
Equity
1 421
1 944
2 214
2 135
1 919
Long-term debt
0
0
—
—
—
Short-term debt
483
265
224
154
64
Total debt
483
265
224
154
64
Financial ratios
5-year trend
EBITDA margin
22.3%
This company
15.8%
Market median
+41% vs market
2020
2024
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
2020
2024
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
2020
2024
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
2020
2024
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
2020
2024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PA
Paul Alhadeff
Board of Directors
2022
KC
Karin Charlotte Johansson
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PA Pharma Development AB also hold positions in
0
other companies.
Person
Role here
Other companies
Paul Alhadeff
Board of Directors
0 companies
Karin Charlotte Johansson
Deputy Board Member
0 companies